Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Inventiva S.A. ADR (IVA)

Inventiva S.A. ADR (IVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 262,073
  • Shares Outstanding, K 42,134
  • Annual Sales, $ 10,060 K
  • Annual Income, $ -58,720 K
  • 60-Month Beta 1.07
  • Price/Sales 56.63
  • Price/Cash Flow N/A
  • Price/Book 3.44
Trade IVA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.99 +16.03%
on 01/09/23
6.82 -15.10%
on 01/18/23
+0.94 (+19.26%)
since 01/06/23
3-Month
3.68 +57.34%
on 11/09/22
6.82 -15.10%
on 01/18/23
+1.50 (+34.97%)
since 11/08/22
52-Week
3.49 +65.79%
on 09/30/22
13.66 -57.61%
on 02/28/22
-7.65 (-56.92%)
since 02/08/22

Most Recent Stories

More News
Humana (HUM) Ups '23 Medicare Advantage Membership Growth View

Humana (HUM) expects 2023 net membership gains to be a minimum of 10.9% from the 2022 projection.

HUM : 494.21 (+2.75%)
AMN : 95.35 (-2.59%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
Why You Should Retain Centene (CNC) in Your Portfolio Now

Divesting operations like PANTHERx, Magellan Specialty Health and others are going to enable Centene (CNC) to intensify its focus on its core Managed Care business.

AMN : 95.35 (-2.59%)
CNC : 72.92 (+2.73%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
What You Need to Know From UnitedHealth's (UNH) Latest Outlook

UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.

UNH : 483.22 (+1.33%)
AMN : 95.35 (-2.59%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?

Cigna (CI) expects its long-term adjusted earnings per share to witness 10-13% average annual growth.

CI : 290.20 (+0.42%)
AMN : 95.35 (-2.59%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
Why You Should Add UnitedHealth (UNH) to Your Portfolio Now

The improvement of the economy is likely to support UnitedHealth's (UNH) commercial business recovery.

UNH : 483.22 (+1.33%)
AMN : 95.35 (-2.59%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
Teladoc (TDOC) Achieves Momentous 50M Milestone in Visits

Of the 50 million visits to Teladoc (TDOC), around one-third took place in the last year alone.

AMN : 95.35 (-2.59%)
TDOC : 31.11 (-2.05%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
Select Medical (SEM) Shares Fall 9.6% Since Q3 Earnings Miss

Select Medical (SEM) reports improved performance in the Rehabilitation Hospital unit for the third quarter.

SEM : 28.08 (-2.67%)
IVA : 5.79 (-6.91%)
BHG : 0.8500 (-5.55%)
ELV : 483.54 (+1.19%)
Why Is Encompass Health (EHC) Up 7.5% Despite Q3 Earnings Miss?

Encompass Health (EHC) intends to open 6-10 de novo locations and increase the bed count by 100-150 per annum, till 2026.

EHC : 60.46 (+2.70%)
IVA : 5.79 (-6.91%)
ELV : 483.54 (+1.19%)
EHAB : 14.64 (-0.95%)
Teladoc (TDOC) Up 1.6% Since Q3 Earnings Beat on Higher Visits

Teladoc (TDOC) projects total visits in the band of 18.4-18.6 million for 2022.

TDOC : 31.11 (-2.05%)
IVA : 5.79 (-6.91%)
BHG : 0.8500 (-5.55%)
ELV : 483.54 (+1.19%)
Why Is Community Health (CYH) Up 27.8% Despite Q3 Earnings Miss?

Community Health (CYH) expects labor inflation for 2023 to be within the 3-4% range.

CYH : 5.14 (-1.15%)
IVA : 5.79 (-6.91%)
BHG : 0.8500 (-5.55%)
ELV : 483.54 (+1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.

See More

Key Turning Points

3rd Resistance Point 6.56
2nd Resistance Point 6.40
1st Resistance Point 6.10
Last Price 5.79
1st Support Level 5.64
2nd Support Level 5.48
3rd Support Level 5.18

See More

52-Week High 13.66
Fibonacci 61.8% 9.78
Fibonacci 50% 8.58
Fibonacci 38.2% 7.38
Last Price 5.79
52-Week Low 3.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar